Find disease awareness content and relevant supporting materials
Long-Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.
Background & aims: Based on results from year 2 of a 5-year trial, in 2012 the US Food and Drug Administration approved the use of a magnetic device to augment lower esophageal sphincter function in patients with gastroesophageal reflux disease (GERD).
Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder
Aim: A substantial proportion of major depressive disorder patients are treatment‐resistant to antidepressant therapy, who require augmentation drugs, or other treatments including electroconvulsive therapy or transcranial magnetic stimulation.
FDA approves full-body magnetic resonance (MR) conditional labeling for the Proclaim Elite Spinal Cord Stimulation (SCS) System.-St Jude Medical.
St. Jude Medical, Inc. announced FDA approval for full-body magnetic resonance (MR) Conditional labeling for the Proclaim Elite Spinal Cord...
Management of Treatment-Resistant Depression: Challenges and Strategies
Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder which does not respond to traditional and first-line therapeutic options. There are several definitions and staging models of TRD and a consensus for each has not yet been established.
Boston Scientific receives FDA approval for EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System, an ImageReady MR-conditional device, which allows patients to undergo magnetic resonance imaging (MRI) safely.
Boston Scientific has received FDA approval for the EMBLEM MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance...
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practise.
The twelve recommendations are intended to advise physicians on the use of imaging modalities when making a clinical diagnosis, and when to apply imaging for monitoring of disease activity and damage.